Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 09/05/2011
PIL Co-Diovan 80/12.5 mg, 160/12.5 mg, 160/25 mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 03/02/2010 and displayed until 09/05/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 10/09/2009 and displayed until 03/02/2010
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 30/12/2004 and displayed until 10/09/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   hydrochlorothiazide
   valsartan